Nektar Therapeutics (NKTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15,116 | 41,032 | 42,988 | 38,894 | 44,252 |
| Marketable Securities | 230,636 | 229,176 | 132,915 | 179,738 | 210,974 |
| Other current assets | 20,514 | 11,149 | 10,663 | 11,281 | 6,066 |
| TOTAL | $266,266 | $281,357 | $186,566 | $229,913 | $261,292 |
| Non-Current Assets | |||||
| PPE Net | 2,060 | 2,826 | 2,988 | 3,162 | 3,411 |
| Investments And Advances | 3,491 | 4,837 | 5,371 | 9,776 | 26,087 |
| Other Non-Current Assets | 8,589 | 12,327 | 12,609 | 13,390 | 13,060 |
| TOTAL | $14,140 | $19,990 | $20,968 | $26,328 | $42,558 |
| Total Assets | $280,406 | $301,347 | $207,534 | $256,241 | $303,850 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,770 | 15,563 | 14,281 | 17,834 | 11,560 |
| Accrued Expenses | 22,271 | 28,594 | 35,099 | 31,254 | 29,972 |
| TOTAL | $53,536 | $66,340 | $71,391 | $70,930 | $61,400 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 137,038 | 149,921 | 160,354 | 171,573 | 181,713 |
| TOTAL | $137,038 | $149,921 | $160,354 | $171,573 | $181,713 |
| Total Liabilities | $190,574 | $216,261 | $231,745 | $242,503 | $243,113 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 28,688 | 20,342 | 19,019 | 12,413 | 12,413 |
| Common Shares | 2 | 2 | 1 | 19 | 1 |
| Retained earnings | -3,760,286 | -3,724,207 | -3,688,685 | -3,647,092 | -3,596,210 |
| Other shareholders' equity | 17 | 56 | -14 | 39 | 61 |
| TOTAL | $89,832 | $85,086 | $-24,211 | $13,738 | $60,737 |
| Total Liabilities And Equity | $280,406 | $301,347 | $207,534 | $256,241 | $303,850 |